glp-1 perte de poids avis Swissmedic met en garde contre des produits « » falsifiés et trompeurs destinés à la Purotyn GLP-1 - Analyse complète

Certain factors may increase the likelihood of experiencing bloating on GLP-1 therapy, including: Pre-existing gastrointestinal conditions such as irritable bowel syndrome (IBS), functional dyspepsia, or small intestinal bacterial overgrowth (SIBO) Rapid dose escalation without adequate titration periods Dietary factors , particularly high intake of fermentable carbohydrates (FODMAPs), fatty foods, or carbonated beverages Concurrent medications that affect gastrointestinal motility Patients should be aware that GLP-1 receptor agonists have been associated with more serious gastrointestinal adverse effects, including pancreatitis (inflammation of the pancreas) and gallbladder disease

Stokes T et al

Results vary based on your dose, metabolism, and adherence to habits like diet and physical activity

Nature 392 , 565568 (1998)